Here are three things to know:
1. Vivex Biomedical is a processor of human tissue, synthetics, mimetic patterning technology and biocellular products.
2. Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets.
3. As per the agreement, Xtant Medical will be entering the cellular bone graft market with a viable cell allograft, OsteoVive. Vivex will process the allograft for Xtant Medical and Xtant Medical will provide national distribution through its sales channels and national contract networks.
More articles on devices:
SpineGuard announces full-year 2015 financial results: 9 facts
Amedica successfully uses 3D printing to create silicon nitride devices: 4 things to know
5 points on the growing small bone & joint orthopedic devices market
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
